These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 21570337)

  • 1. CCR2-64I gene polymorphism increase susceptibility to oral cancer.
    Chen MK; Yeh KT; Chiou HL; Lin CW; Chung TT; Yang SF
    Oral Oncol; 2011 Jul; 47(7):577-82. PubMed ID: 21570337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic polymorphism of CCR2-64I increased the susceptibility of hepatocellular carcinoma.
    Yeh CB; Tsai HT; Chen YC; Kuo WH; Chen TY; Hsieh YH; Chou MC; Yang SF
    J Surg Oncol; 2010 Sep; 102(3):264-70. PubMed ID: 20740585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MCP-1 and CCR2 gene variants in oral squamous cell carcinoma.
    Bektas-Kayhan K; Unur M; Boy-Metin Z; Cakmakoglu B
    Oral Dis; 2012 Jan; 18(1):55-9. PubMed ID: 21883707
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The association between hypoxia inducible factor-1alpha gene polymorphisms and increased susceptibility to oral cancer.
    Chen MK; Chiou HL; Su SC; Chung TT; Tseng HC; Tsai HT; Yang SF
    Oral Oncol; 2009 Dec; 45(12):e222-6. PubMed ID: 19717330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of polymorphisms in MCP-1, CCR2, and CCR5 genes with the risk and clinicopathological characteristics of prostate cancer.
    Kucukgergin C; Isman FK; Cakmakoglu B; Sanli O; Seckin S
    DNA Cell Biol; 2012 Aug; 31(8):1418-24. PubMed ID: 22612293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCR2-64I is a risk factor for development of bladder cancer.
    Narter KF; Agachan B; Sozen S; Cincin ZB; Isbir T
    Genet Mol Res; 2010 Apr; 9(2):685-92. PubMed ID: 20449800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCR2-64I polymorphism is associated with Non-Small Cell Lung Cancer in Tunisian patients.
    Rafrafi A; Kaabachi S; Kaabachi W; Chahed B; Amor AB; Mbarik M; Charrad R; Salah MO; Hamzaoui K; Sassi FH
    Hum Immunol; 2015 May; 76(5):348-54. PubMed ID: 25797207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of polymorphisms in the MCP-1 and CCR2 genes with the risk of cancer: a meta-analysis.
    Cho YA; Kim J
    Cytokine; 2013 Oct; 64(1):213-20. PubMed ID: 23876399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of chemokine and chemokine receptor gene variants on the susceptibility and clinicopathological characteristics of bladder cancer.
    Kucukgergin C; Isman FK; Dasdemir S; Cakmakoglu B; Sanli O; Gokkusu C; Seckin S
    Gene; 2012 Dec; 511(1):7-11. PubMed ID: 22982413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single nucleotide polymorphisms and haplotypes of MMP-14 are associated with the risk and pathological development of oral cancer.
    Weng CJ; Chen MK; Lin CW; Chung TT; Yang SF
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S319-27. PubMed ID: 21512861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of MCP-1 and CCR2 polymorphisms with the risk of late acute rejection after renal transplantation in Korean patients.
    Kang SW; Park SJ; Kim YW; Kim YH; Sohn HS; Yoon YC; Joo H; Jeong KH; Lee SH; Lee TW; Ihm CG
    Int J Immunogenet; 2008 Feb; 35(1):25-31. PubMed ID: 18186797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic association of monocyte chemoattractant protein 1 (MCP-1)-2518 polymorphism in Mexican patients with transitional cell carcinoma of the bladder.
    Vázquez-Lavista LG; Lima G; Gabilondo F; Llorente L
    Urology; 2009 Aug; 74(2):414-8. PubMed ID: 19646633
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between CCR2-V64I polymorphism and cancer risk: a meta-analysis.
    Huang Y; Chen H; Wang J; Bunjhoo H; Xiong W; Xu Y; Zhao J
    Gene; 2013 Jul; 524(1):54-8. PubMed ID: 23612252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic polymorphisms of ADH1C and CYP2E1 and risk of oral squamous cell carcinoma.
    Brocic M; Supic G; Zeljic K; Jovic N; Kozomara R; Zagorac S; Zlatkovic M; Magic Z
    Otolaryngol Head Neck Surg; 2011 Oct; 145(4):586-93. PubMed ID: 21705789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility to oral cancer by genetic polymorphisms at CYP1A1, GSTM1 and GSTT1 loci among Indians: tobacco exposure as a risk modulator.
    Anantharaman D; Chaubal PM; Kannan S; Bhisey RA; Mahimkar MB
    Carcinogenesis; 2007 Jul; 28(7):1455-62. PubMed ID: 17307803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The association of monocyte chemotactic protein-1 and CC chemokine receptor 2 gene variants with chronic obstructive pulmonary disease.
    Bai J; Song H; Cai C; Zhang M; Xu S; Tan J
    DNA Cell Biol; 2012 Jun; 31(6):1058-63. PubMed ID: 22276574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional genetic variants of CTLA-4 and risk of tobacco-related oral carcinoma in high-risk North Indian population.
    Bharti V; Mohanti BK; Das SN
    Hum Immunol; 2013 Mar; 74(3):348-52. PubMed ID: 23246583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia inducible factor-1alpha gene polymorphism G1790A and its interaction with tobacco and alcohol consumptions increase susceptibility to hepatocellular carcinoma.
    Hsiao PC; Chen MK; Su SC; Ueng KC; Chen YC; Hsieh YH; Liu YF; Tsai HT; Yang SF
    J Surg Oncol; 2010 Aug; 102(2):163-9. PubMed ID: 20648588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of genetic polymorphisms of stromal cell-derived factor-1 and its receptor, CXCR4, to the susceptibility and clinicopathologic development of oral cancer.
    Teng YH; Liu TH; Tseng HC; Chung TT; Yeh CM; Li YC; Ou YH; Lin LY; Tsai HT; Yang SF
    Head Neck; 2009 Oct; 31(10):1282-8. PubMed ID: 19373784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The +190 G/A (rs1799864) polymorphism in the C-C chemokine receptor 2 (CCR2) gene is associated with susceptibility to multiple sclerosis in HLA-DRB1*15:01-negative individuals.
    Javor J; Párnická Z; Michalik J; Čopíková-Cudráková D; Shawkatová I; Ďurmanová V; Gmitterová K; Klímová E; Bucová M; Buc M
    J Neurol Sci; 2015 Feb; 349(1-2):138-42. PubMed ID: 25604634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.